Endocrinology, Diabetes, and Metabolic Risk

Intermittent hypoxia and sympathetic activation are linked to insulin resistance, dysglycemia, metabolic syndrome, and type 2 diabetes risk—and airway treatment can improve markers in selected patients.

  • Prospective Study of the Association Between Sleep-Disordered Breathing and Hypertension.

    Peppard PE, Young T, Palta M, Skatrud J.

    Landmark prospective evidence that sleep-disordered breathing drives cardiometabolic risk trajectories, forming the backbone for the “OSA is systemic” model.

    [New England Journal of Medicine, 2000]

    View Article

  • Meta-Analyses of the Association of Sleep Apnea with Insulin Resistance, and the Effects of CPAP on HOMA-IR.

    Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ.

    Shows OSA is associated with insulin resistance and that CPAP can improve insulin resistance, especially in non-diabetic cohorts, supporting airway treatment as an adjunct metabolic lever.

    [Sleep Medicine Reviews, 2015]

    View Article

  • Alterations in Glucose Disposal in Sleep-Disordered Breathing.

    Punjabi NM, Beamer BA.

    Classic mechanistic human evidence linking sleep-disordered breathing to impaired glucose metabolism independent of obvious confounders.

    [American Journal of Respiratory and Critical Care Medicine, 2009]

    View Article

  • Obstructive Sleep Apnea and Metabolic Syndrome: a Systematic Review and Meta-Analysis.

    Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G.

    Synthesizes evidence connecting OSA with metabolic syndrome components, supporting routine screening when patients present with abdominal adiposity, dyslipidemia, and hypertension.

    [Journal of the American College of Cardiology, 2013]

    View Article

  • Obstructive Sleep Apnea and Type 2 Diabetes: a Bidirectional Relationship.

    Tasali E, Mokhlesi B, Van Cauter E.

    Clarifies why OSA both contributes to and is worsened by diabetes, giving endocrinology an actionable framework for screening and co-management.

    [Chest, 2008]

    View Article

  • Sleep-Disordered Breathing and Type 2 Diabetes: a Deadly Duo.

    Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ.

    Clinically oriented synthesis on shared pathways and outcomes, suitable for endocrinology-facing education and referral protocols.

    [Journal of Clinical Sleep Medicine, 2024]

    View Article

  • Obstructive Sleep Apnea, Prediabetes and Progression of Type 2 Diabetes

    Meta-analysis showing OSA is associated with increased incidence/progression of diabetes and prediabetes, supporting airway evaluation as part of metabolic risk management.

    [Journal of Diabetes Investigation, 2023]

    View Article

  • Effect of CPAP on Insulin Resistance and HbA1c in Men with OSA and Type 2 Diabetes (RCT).

    Steiropoulos P, et al.

    Randomized trial testing whether CPAP improves glycemic control in established diabetes, useful for setting realistic expectations and identifying who benefits most.

    [Thorax, 2007]

    View Article

Link List

Select + copy

Share this research with a colleague, a referring physician, or a patient who wants to go deeper. Copy the links below and send them directly.

https://pubmed.ncbi.nlm.nih.gov/10922424/
https://europepmc.org/articles/PMC4365462
https://pubmed.ncbi.nlm.nih.gov/19213879/
https://pubmed.ncbi.nlm.nih.gov/24013081/
https://pubmed.ncbi.nlm.nih.gov/18988763/
https://link.springer.com/article/10.5664/jcsm.11462
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.13793
https://thorax.bmj.com/content/62/11/969